Lupin informs about press release

26 May 2025 Evaluate
Lupin has informed that it enclosed a Press Release as regards, the Company has entered into a license and supply agreement with SteinCares, a leading specialty healthcare company in Latin America, for commercialization of Lupin’s biosimilar ranibizumab across Latin America excluding Mexico and Argentina.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2358.70 17.95 (0.77%)
11-Mar-2026 14:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1828.85
Dr. Reddys Lab 1323.10
Cipla 1334.50
Zydus Lifesciences 927.90
Lupin 2358.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×